Amerisource Health Services LLC recalls Glimepiride Tablets, USP, 4 mg, RX, Packaged as a) 100-count bottle, NDC# 68001-179-00; b) 500-count bottle, NDC# 68001-
Recalled May 31, 2023 · FDA recall D-0759-2023 · Amerisource Health Services
Hazard
CGMP Deviations: recalling drug products following an FDA inspection. · FDA Class II
Units
129,849 bottles
Sold at
Nationwide USA
Description
CGMP Deviations: recalling drug products following an FDA inspection.
Product
Glimepiride Tablets, USP, 4 mg, RX, Packaged as a) 100-count bottle, NDC# 68001-179-00; b) 500-count bottle, NDC# 68001-179-03, Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213. INDIA. For BluePoint Laboratories
Manufacturer(s)
Amerisource Health Services LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →